News
Latest News
The collaboration will support community change to address inequality and drive impact
More than 125 life science leaders and representatives from more than 65 companies joined the leading trade…
The relationship will support educational programs for all ages at the historic site
We are excited to announce NewYorkBIO’s new Incubator & Accelerator Membership tiers, created to empower…
In 2025, NewYorkBIO launched New York Bio Connect, a first-of-its-kind resource hub. Designed for…
The award celebrates innovation, economic impact, and leadership in New York City’s thriving life sciences…
New York’s leading life science advocacy association and economic development organizations develop resource…
StatNews 09/11/2026
A late-stage clinical trial found that, when combined with an SMN2-targeting drug, Isembyld caused ...
09/11/2026
Platinum chemotherapy's long-term effects, surprising heart failure drug failures, and more biotech ...
09/11/2026
The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. ...
09/10/2026
UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more ...
09/10/2026
A Roivant lung disease drug has succeeded in a mid-stage study. But the drug’s origins ...
09/10/2026
Before the end of September, UniQure is expected to report four-year results from the closely ...
09/09/2026
A new FDA CBER head, AI company Schrodinger with a new startup, and more biotech news from The ...
09/09/2026
Caspian Therapeutics, is launching with $50 million in financing to develop menin inhibitors for ...
09/08/2026
The moves bring stability to an agency that's been rocked by the exits of top leadership.